NCT06556628

Brief Summary

The goal of this study is to collect febrile, healthy, and in some instances cold temperature data from human subjects ranging from newborns to geriatrics. This data will be used to develop a new thermometer.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 11, 2022

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

August 12, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 16, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

August 16, 2024

Status Verified

August 1, 2024

Enrollment Period

3.1 years

First QC Date

August 12, 2024

Last Update Submit

August 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical Bias

    The mean difference between output temperatures of the clinical thermometer under test

    Immediately after the diagnostic test

Secondary Outcomes (2)

  • Repeatability

    Immediately after the diagnostic test

  • Limits of Agreement

    Immediately after the diagnostic test

Study Arms (3)

Fever

Elevated oral temperature of 37.5C or higher or elevated axillary temperature of 37.2C or higher.

Device: Increased Body Temperatures

Healthy

Oral temperature between 36-37.4C Axillary temperature between 36-37.1C

Cold

Oral or axillary temperatures below 36C

Interventions

Collecting data on patients whose body temperatures increase due to fighting an illness.

Fever

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects recruited to participate in this study may range in age from normal weight (≥2.5kg), full-term (37 weeks gestation) newborns to geriatric adults. The subject may be anyone who is willing to have their temperature taken who also meets the eligibility criteria. Study subjects may have normal, febrile, or cold temperatures.

You may qualify if:

  • Age: normal weight (≥2.5kg), full-term (37 weeks gestation) newborn to geriatric adult.
  • Participant, legal guardian, or healthcare proxy is able to give consent to participate.
  • Participant, legal guardian, or healthcare proxy speaks fluent English.

You may not qualify if:

  • The subject has anatomical abnormalities that would affect temperature.
  • The subject has blood or drainage in the external ear canal.
  • The subject has had something in their ear for a prolonged period, such as a hearing aid or headphones. The subject may be included if the hearing aid or headphones are removed at least 30 minutes prior to taking ear temperature.
  • The subject has been lying on ear within 30 minutes of data collection. The subject may be included if they wait 30 minutes prior to having an ear temperature measurement taken.
  • The subject exhibits symptoms of an acute or chronic inflammatory condition of the external ear canal. An example would be swimmer's ear. The subject may be included if the acute or chronic inflammatory condition is isolated to one ear, then the other ear may be used for data collection.
  • The subject has an ear obstruction or excess cerumen build-up.
  • The subject is in acute distress, i.e., severe pain, severe emotional distress or agitation that would inhibit them from participating in a tympanic ear temperature study.
  • The subject has any known contraindication to oral, ear, or axillary temperature measurements.
  • The subject has used ear drops in the last 8 hours. The subject may be included if the other ear was not medicated with ear drops in the last 8 hours.
  • The subject (age 5+) has consumed food or drink, or smoked, within the last 20 minutes. The subject may be included if they wait 20 minutes prior to taking oral temperature.
  • The subject has taken an antipyretic (ex: Tylenol, Motrin, Aspirin) in the last 120 minutes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baxter

Skaneateles, New York, 13153, United States

Location

MeSH Terms

Conditions

Body Temperature ChangesFever

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2024

First Posted

August 16, 2024

Study Start

April 11, 2022

Primary Completion

May 31, 2025

Study Completion

May 31, 2025

Last Updated

August 16, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations